Amneal Pharmaceuticals Inc (AMRX)

Jan 20, 2025

Assenagon Asset Management S.A. Decreases Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Jan 20, 2025

Jan 19, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update - MarketBeat

Jan 19, 2025

Jan 18, 2025

Hennessy Advisors Inc. Acquires 106,600 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Jan 18, 2025

Jan 17, 2025

Amneal Is Targeting 70% Of Untapped Biologics In The ‘Golden Era’ Of Biosimilars - Citeline News & Insights

Jan 17, 2025

Jan 16, 2025

Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year? - MSN

Jan 16, 2025

Jan 16, 2025

FDA grants tentative approval for Amneal generic of Bausch Health's Xiafan - MSN

Jan 16, 2025

Jan 16, 2025

Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence; AI Driving Market TransformationTechnavio - The Malaysian Reserve

Jan 16, 2025

Jan 15, 2025

Amneal expects to meet or top annual guidance - MSN

Jan 15, 2025

Jan 15, 2025

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2024 Earnings Guidance - MarketBeat

Jan 15, 2025

Jan 15, 2025

Amneal Pharmaceuticals Maintains Transparency with SEC Filing - TipRanks

Jan 15, 2025

Jan 13, 2025

JPMorgan Chase & Co. Grows Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Jan 13, 2025

Jan 12, 2025

Insider Sell: Gautam Patel Sells 62,590 Shares of Amneal Pharmac - GuruFocus.com

Jan 12, 2025

Jan 11, 2025

Amneal Pharmaceuticals director Patel sells $501,345 in stock By Investing.com - Investing.com Canada

Jan 11, 2025

Jan 10, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Director Gautam Patel Sells 62,590 Shares - MarketBeat

Jan 10, 2025

Jan 10, 2025

The 3.1% return this week takes Amneal Pharmaceuticals' (NASDAQ:AMRX) shareholders three-year gains to 74% - Simply Wall St

Jan 10, 2025

Jan 09, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 09, 2025

Jan 08, 2025

Testosterone Replacement Therapy Market to Grow by USD 461 Million (2025-2029), Driven by Awareness Initiatives on Hypogonadism and AI-Driven Market TransformationTechnavio - The Malaysian Reserve

Jan 08, 2025

Jan 08, 2025

Amneal (AMRX) Upgraded to Strong Buy: Here's Why - MSN

Jan 08, 2025

Jan 08, 2025

Amneal Sues Sandoz to Block Copies of New Parkinson's Drug (1) - Bloomberg Law

Jan 08, 2025

Jan 07, 2025

Amneal Calls Teva's IP Delisting Panic 'Theatrical Distraction' - Law360

Jan 07, 2025

Jan 06, 2025

Amneal Pharmaceuticals director Gautam Patel sells $139,454 in stock By Investing.com - Investing.com Nigeria

Jan 06, 2025

Jan 06, 2025

Insider Selling: Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Director Sells 17,410 Shares of Stock - MarketBeat

Jan 06, 2025

Jan 06, 2025

Amneal Pharmaceuticals director Gautam Patel sells $139,454 in stock - Investing.com India

Jan 06, 2025

Jan 06, 2025

CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices - Benzinga

Jan 06, 2025

Jan 06, 2025

Here’s Why Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey

Jan 06, 2025

Jan 04, 2025

Jane Street Group LLC Has $681,000 Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Jan 04, 2025

Dec 28, 2024

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Sees Large Decrease in Short Interest - MarketBeat

Dec 28, 2024

Dec 26, 2024

Geode Capital Management LLC Purchases 378,136 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 26, 2024

Dec 26, 2024

Barclays PLC Buys 169,756 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 26, 2024

Dec 23, 2024

Amneal Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:AMRX) - MarketBeat

Dec 23, 2024

Dec 23, 2024

Epinephrine Autoinjector Market Growth, Trends & Forecast - openPR

Dec 23, 2024

Dec 22, 2024

State Street Corp Boosts Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 22, 2024

Dec 21, 2024

82,596 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Acquired by Wellington Management Group LLP - MarketBeat

Dec 21, 2024

Dec 20, 2024

Teva loses US appeal to keep inhaler patents on FDA protected drug list - Reuters

Dec 20, 2024

Dec 19, 2024

Amneal Pharmaceuticals (NASDAQ:AMRX) Rating Lowered to "Buy" at StockNews.com - MarketBeat

Dec 19, 2024

Dec 17, 2024

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 4.5%Here's What Happened - MarketBeat

Dec 17, 2024

Dec 16, 2024

Teva Makes Two Inhalers Free For Charity Amid Ongoing Patent Battle With Amneal - News & Insights

Dec 16, 2024

Dec 15, 2024

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.00 Average Price Target from Analysts - MarketBeat

Dec 15, 2024

Dec 15, 2024

BNP Paribas Financial Markets Sells 402,852 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 15, 2024

Dec 13, 2024

Amneal Pharmaceuticals' SWOT analysis: generic drug maker's stock poised for growth - Investing.com Australia

Dec 13, 2024

Dec 12, 2024

Parkinson's Disease Market to Reach New Heights in Growth - openPR

Dec 12, 2024

Dec 11, 2024

SERD Therapeutics Market Key Players AnalysisAmneal - openPR

Dec 11, 2024

Dec 10, 2024

Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence and AI-Powered Market TransformationTechnavio - The Malaysian Reserve

Dec 10, 2024

Dec 10, 2024

Jacobs Levy Equity Management Inc. Sells 189,881 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 10, 2024

Dec 09, 2024

Charles Schwab Investment Management Inc. Buys 202,863 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Dec 09, 2024